Sign In
Buy DOCS
$21.04
-0.470 (-2.19%)
At Close: Jun 03, 2026
1 Growth Stock Down Nearly 40% to Buy and Hold For 10 Years
10:15am, Wednesday, 16'th Aug 2023
Doximity is profitable and boasts high gross and net margins. The company's platform displays the flywheel effect, a powerful moat.
Down 39.9%, Is Doximity a Buy on the Dip?
05:32am, Monday, 14'th Aug 2023
Doximity shares recently fell in response to a revised forward outlook management shared during its fiscal first-quarter earnings report. Over half a million unique U.S. physicians used Doximity's dig
Time to Cut and Run on This 1 Formerly Promising Digital Health Stock?
10:07am, Saturday, 12'th Aug 2023
Doximity's revised guidance for the current fiscal year was horrendous. The business is still growing a bit and is highly profitable.
Why Doximity Stock Plunged 29% This Week
11:09pm, Friday, 11'th Aug 2023
Doximity announced solid fiscal first-quarter 2024 results that exceeded expectations. But the online networking service for medical professionals is also laying off 10% of its workforce and lowered a
Why Shares of Doximity Are Falling Wednesday
12:21pm, Wednesday, 09'th Aug 2023
Doximity said it was trimming its workforce by 10%. The company reported increased revenue and net income.
Why Is Doximity (DOCS) Stock Down 23% Today?
08:43am, Wednesday, 09'th Aug 2023
Doximity (NYSE: DOCS ) stock is falling hard on Wednesday after the medical cloud services company released earnings for its fiscal first quarter of 2024. The drop in DOCS stock is despite the compan
Doximity, Inc. (DOCS) Q1 2024 Earnings Call Transcript
10:54pm, Tuesday, 08'th Aug 2023
Doximity, Inc. (NYSE:DOCS ) Q1 2024 Earnings Conference Call August 8, 2023 5:00 PM ET Company Participants Perry Gold - VP of IR Jeffrey Tangney - Co-Founder and CEO Anna Bryson - CFO Nate Gross - Co
Here's What Key Metrics Tell Us About Doximity (DOCS) Q1 Earnings
07:41pm, Tuesday, 08'th Aug 2023
While the top- and bottom-line numbers for Doximity (DOCS) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare t
Doximity (DOCS) Surpasses Q1 Earnings and Revenue Estimates
06:56pm, Tuesday, 08'th Aug 2023
Doximity (DOCS) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.14 per share a year ago.
ELV or DOCS: Which Is the Better Value Stock Right Now?
01:05pm, Monday, 24'th Jul 2023
Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and Doximity (DOCS). But which of these two stocks presents investors with the bett
Doximity to Release Fiscal 2024 First Quarter Results on August 8, 2023
04:01pm, Tuesday, 18'th Jul 2023
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter e
4 Top Stocks to Buy in July and Hold Forever
10:00am, Monday, 10'th Jul 2023
Doximity's massive platform for doctors is the perfect setting for healthcare advertisers. Declining fertility trends make Progyny's services all the more important to its customers.
BLCO or DOCS: Which Is the Better Value Stock Right Now?
01:05pm, Thursday, 06'th Jul 2023
Investors interested in Medical Services stocks are likely familiar with Bausch + Lomb (BLCO) and Doximity (DOCS). But which of these two stocks is more attractive to value investors?
Doximity: Continue To See Positive Upside From Current Stock Level
10:22pm, Tuesday, 04'th Jul 2023
I recommend buying DOCS, given its benefits to the healthcare industry and pharmaceutical companies, and its potential to meet long-term revenue goals of $1 billion by FY28. DOCS should benefit from i
3 No-Brainer Growth Stocks to Buy in July and Hold for the Next Decade
06:07am, Tuesday, 04'th Jul 2023
Growth stocks are up sharply this year, but there are at least a few that have been overlooked. Doximity's social media applications for physicians are more popular than ever, but the stock is down to
